Antengene Submits NDAs for XPOVIO® (Selinexor) in Multiple APAC Markets for rrMM and rrDLBCL

PR Newswire
December 3, 2020 — 20:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: China Donald Trump Export Exports healthcare Hong Kong medicine Pacific Shanghai singapore South Korea stock market Trump

Related News:

CFGI Acquires Leading German CFO Advisory Firm PAS Financial Advisory AG

May 3, 2024 — 09:00

QANDA Named to TIME’s Inaugural List of the World’s Top EdTech Companies in 2024

May 3, 2024 — 07:27

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

May 2, 2024 — 07:01

Keeper Security Forges Cybersecurity Partnership With Williams Racing

May 2, 2024 — 07:00

MGM China Reports 2024 First Quarter Results

May 2, 2024 — 06:16

Chinese president’s upcoming visit to bring new hope to Serbia’s development: Vucic

May 1, 2024 — 11:51

LYB to build integrated plastic waste recycling hub in Knapsack

April 29, 2024 — 19:00

Every Dollar Lost to Fraud in Australia Costs Firms AUD$3.68 According to LexisNexis True Cost of Fraud Study

April 29, 2024 — 07:00

CATL and Beijing Hyundai sign strategic agreement on EV batteries

April 28, 2024 — 11:10